{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:55:25Z","timestamp":1792205725067,"version":"4.4.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072996"],"award-info":[{"award-number":["82072996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273202"],"award-info":[{"award-number":["82273202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303328"],"award-info":[{"award-number":["82303328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017662","name":"Chinese Stomatological Association","doi-asserted-by":"publisher","award":["2023PYRC001"],"award-info":[{"award-number":["2023PYRC001"]}],"id":[{"id":"10.13039\/501100017662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042023kf0141"],"award-info":[{"award-number":["2042023kf0141"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023020201020516"],"award-info":[{"award-number":["2023020201020516"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2504200"],"award-info":[{"award-number":["2022YFC2504200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ebiom.2024.105154","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T06:11:11Z","timestamp":1715667071000},"page":"105154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-6454","authenticated-orcid":false,"given":"Wen-Ping","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-8013","authenticated-orcid":false,"given":"Zhi-Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2024.105154_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"10135","key":"10.1016\/j.ebiom.2024.105154_bib2","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ebiom.2024.105154_bib3","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.ebiom.2024.105154_bib4","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105154_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ebiom.2024.105154_bib6","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6230","key":"10.1016\/j.ebiom.2024.105154_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2024.105154_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2023.02.007","article-title":"Artificial intelligence in cancer immunotherapy: applications in neoantigen recognition, antibody design and immunotherapy response prediction","volume":"91","author":"Li","year":"2023","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T\u00a0cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2024.105154_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105154_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8(+) T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canlet.2016.02.057","article-title":"Prevailing over T cell exhaustion: new developments in the immunotherapy of pancreatic cancer","volume":"381","author":"Bauer","year":"2016","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105154_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105154_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221920","article-title":"Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice","volume":"220","author":"Collier","year":"2023","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105154_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8(+) T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2024.105154_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216105","article-title":"Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma","volume":"558","author":"Zhang","year":"2023","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/00220345231151685","article-title":"Tertiary lymphoid structure raises survival and immunotherapy in HPV(-) HNSCC","volume":"102","author":"Li","year":"2023","journal-title":"J\u00a0Dent Res"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105154_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.102948","article-title":"Risk modeling of single-cell transcriptomes reveals the heterogeneity of immune infiltration in hepatocellular carcinoma","volume":"299","author":"Wang","year":"2023","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2024.105154_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216293","article-title":"Tertiary lymphoid structures and cytokines interconnections: the implication in cancer immunotherapy","volume":"568","author":"Li","year":"2023","journal-title":"Cancer Lett"},{"issue":"6576","key":"10.1016\/j.ebiom.2024.105154_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105154_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/jimmunol.2000873","article-title":"Tertiary lymphoid structures: diversity in their development, composition, and role","volume":"206","author":"Gago da Graca","year":"2021","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2024.105154_bib23","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3389\/fimmu.2017.01830","article-title":"Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease?","volume":"8","author":"Colbeck","year":"2017","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105154_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"7791","key":"10.1016\/j.ebiom.2024.105154_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.ebiom.2024.105154_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B\u00a0cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.ebiom.2024.105154_bib27","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B\u00a0cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105154_bib28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202000061","article-title":"Exosomes in tumor immunotherapy: mediator, drug carrier, and prognostic biomarker","volume":"4","author":"Wan","year":"2020","journal-title":"Adv Biosyst"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105154_bib31","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion'","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105154_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"7644","key":"10.1016\/j.ebiom.2024.105154_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature21508","article-title":"Immunology: the chronicles of T-cell exhaustion","volume":"543","author":"Amezquita","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib35","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41590-022-01337-5","article-title":"Divergent clonal differentiation trajectories of T cell exhaustion","volume":"23","author":"Daniel","year":"2022","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib36","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T cell therapy for solid tumors: bright future or dark reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol Ther"},{"issue":"6422","key":"10.1016\/j.ebiom.2024.105154_bib37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105154_bib38","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","article-title":"Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes","volume":"187","author":"Gallimore","year":"1998","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105154_bib39","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105154_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"issue":"6583","key":"10.1016\/j.ebiom.2024.105154_bib41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105154_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","article-title":"A\u00a0phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers","volume":"40","author":"Hanada","year":"2022","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105154_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105154_bib44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s43018-022-00433-7","article-title":"Single-cell meta-analyses reveal responses of tumor-reactive CXCL13(+) T cells to immune-checkpoint blockade","volume":"3","author":"Liu","year":"2022","journal-title":"Nat Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105154_bib45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105154_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/intimm\/dxaa039","article-title":"Impact of multiple hits with cognate antigen on memory CD8+ T-cell fate","volume":"32","author":"Takamura","year":"2020","journal-title":"Int Immunol"},{"issue":"64","key":"10.1016\/j.ebiom.2024.105154_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg7836","article-title":"A\u00a0reservoir of stem-like CD8(+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response","volume":"6","author":"Connolly","year":"2021","journal-title":"Sci Immunol"},{"issue":"6594","key":"10.1016\/j.ebiom.2024.105154_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd5926","article-title":"Reversible CD8 T cell-neuron cross-talk causes aging-dependent neuronal regenerative decline","volume":"376","author":"Zhou","year":"2022","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105154_bib49","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.trecan.2022.04.003","article-title":"Spatial determinants of CD8(+) T cell differentiation in cancer","volume":"8","author":"Tooley","year":"2022","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105154_bib50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/imm.13568","article-title":"Single-cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer","volume":"168","author":"Xia","year":"2023","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41467-022-35238-w","article-title":"A\u00a0comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer","volume":"14","author":"Tietscher","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105154_bib54","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2023.03.008","article-title":"Single-cell profiling of tumor immune microenvironment reveals immune irresponsiveness in gastric signet-ring cell carcinoma","volume":"165","author":"Chen","year":"2023","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105154_bib56","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib57","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","article-title":"A\u00a0single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105154_bib58","article-title":"Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma","volume":"10","author":"Yang","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105154_bib59","article-title":"An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105154_bib60","article-title":"PD-1(+)CXCR5(-)CD4(+) Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma","volume":"9","author":"Li","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105154_bib61","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1158\/0008-5472.CAN-21-3714","article-title":"Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer","volume":"82","author":"Singh","year":"2022","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105154_bib62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/cancers14020294","article-title":"Potential role of CXCL13\/CXCR5 signaling in immune checkpoint inhibitor treatment in cancer","volume":"14","author":"Hsieh","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105154_bib63","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B\u00a0cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91487","article-title":"CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer","volume":"2","author":"Gu-Trantien","year":"2017","journal-title":"JCI Insight"},{"issue":"7957","key":"10.1016\/j.ebiom.2024.105154_bib65","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-023-05771-9","article-title":"Antibodies against endogenous retroviruses promote lung cancer immunotherapy","volume":"616","author":"Ng","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105154_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib67","article-title":"Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1\/PD-1 efficacy","volume":"9","author":"Niogret","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105154_bib68","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41577-022-00796-z","article-title":"TGFbeta control of immune responses in cancer: a holistic immuno-oncology perspective","volume":"23","author":"Nixon","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF-beta-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures","volume":"55","author":"Chaurio","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105154_bib72","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105154_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188799","article-title":"CXCL13-CXCR5 axis: regulation in inflammatory diseases and cancer","volume":"1877","author":"Wang","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105154_bib74","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105154_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105154_bib76","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/eji.201546043","article-title":"TGF-beta induces the differentiation of human CXCL13-producing CD4(+) T cells","volume":"46","author":"Kobayashi","year":"2016","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105154_bib77","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157215","article-title":"CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer","volume":"7","author":"Ukita","year":"2022","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib78","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/2326-6066.CIR-17-0131","article-title":"Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction","volume":"5","author":"Colbeck","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105154_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145343","article-title":"Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma","volume":"132","author":"Takata","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2024.105154_bib80","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2016.00520","article-title":"Regulators of Tfh cell differentiation","volume":"7","author":"Jogdand","year":"2016","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105154_bib81","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","article-title":"Targeting T(FH) cells in human diseases and vaccination: rationale and practice","volume":"23","author":"Yu","year":"2022","journal-title":"Nat Immunol"},{"issue":"82","key":"10.1016\/j.ebiom.2024.105154_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade8162","article-title":"Human T follicular helper clones seed the germinal center-resident regulatory pool","volume":"8","author":"Le Coz","year":"2023","journal-title":"Sci Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib83","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/ni.3837","article-title":"Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection","volume":"18","author":"Botta","year":"2017","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105154_bib84","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T\u00a0cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"issue":"691","key":"10.1016\/j.ebiom.2024.105154_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1016","article-title":"Multiomics and spatial mapping characterizes human CD8(+) T cell states in cancer","volume":"15","author":"Naulaerts","year":"2023","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib86","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210749","article-title":"In\u00a0vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue","volume":"219","author":"Li","year":"2022","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105154_bib87","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105154_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2023.09.028","article-title":"Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures","volume":"172","author":"Li","year":"2023","journal-title":"Acta Biomater"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105154_bib89","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B\u00a0cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ebiom.2024.105154_bib90","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T\u00a0cell exhaustion","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib91","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","article-title":"Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance","volume":"29","author":"Chu","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105154_bib92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12885-015-1116-1","article-title":"Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients","volume":"15","author":"Figenschau","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105154_bib93","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","article-title":"Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses","volume":"43","author":"Joshi","year":"2015","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105154_bib94","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/ni.3290","article-title":"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma","volume":"16","author":"Finkin","year":"2015","journal-title":"Nat Immunol"},{"issue":"21","key":"10.1016\/j.ebiom.2024.105154_bib95","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3390\/ijms21218407","article-title":"High stroma T-cell infiltration is associated with better survival in stage pT1 bladder cancer","volume":"21","author":"Hulsen","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib96","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","article-title":"Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma","volume":"70","author":"Calderaro","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105154_bib97","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s40425-019-0736-4","article-title":"Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors","volume":"7","author":"Matsubara","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105154_bib98","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jcmgh.2021.06.023","article-title":"Pancreatic cancer chemotherapy is potentiated by induction of tertiary lymphoid structures in mice","volume":"12","author":"Delvecchio","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105154_bib99","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105154_bib100","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: an intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105154_bib101","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105154_bib102","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41590-023-01578-y","article-title":"Hallmarks of CD8(+) T cell dysfunction are established within hours of tumor antigen encounter before cell division","volume":"24","author":"Rudloff","year":"2023","journal-title":"Nat Immunol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:37:19Z","timestamp":1778873839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424001890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":102,"alternative-id":["S2352396424001890"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105154","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105154"}}